George Ng, the Chief Executive Officer of Processa Pharmaceuticals , Inc. (NASDAQ:PCSA), has recently acquired 87,200 shares of the company's common stock. According to InvestingPro data ...

In this article, we are going to take a look at where Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) stands against the other cheap stocks insiders are buying recently. Why should we be interested ...

Processa Pharmaceuticals, Inc. announced the pricing of a public offering aimed at raising approximately $5 million, with participation from its CEO, board members, and institutional investors.

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO CEO & Investor Conference taking place on February 10-11, 2025, in New York City. The company's management will present a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

What are Processa Pharmaceuticals Inc Insiders Doing? At Processa Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last ...

TORINO – Dovendo piantare un chiodo al quale appendere un elemento di stabilità, bisogna partire da quello su cui ha martellato Giuntoli: “Thiago Motta non è in discussione”. Lo ha detto alla squadra ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...